CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Local vs Import Glaucoma and Cataract Devices Analysis
3.4. Porters Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Technological advancements in cataract and glaucoma surgery devices
3.5.1.2. Rise in geriatric population
3.5.1.3. Increase in focus on training for eye physicians and improve customer awareness

3.5.2. Restrains

3.5.2.1. Low awareness among people related to eye disorders
3.5.2.2. High cost of cataract and glaucoma surgeries and risk of post-operative complications associated with the glaucoma surgeries

3.5.3. Opportunity

3.5.3.1. Increase in transition toward minimally invasive surgeries for glaucoma treatment

CHAPTER 4: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. Glaucoma Surgery Devices

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast, by type
4.2.4. Market size and forecast, by zone
4.2.5. Implant & stent

4.2.5.1. Market size and forecast, by zone

4.2.6. Glaucoma drainage

4.2.6.1. Market size and forecast, by zone

4.2.7. Glaucoma laser device

4.2.7.1. Market size and forecast, by zone

4.3. Cataract Surgery Devices

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast, by type
4.3.4. Market size and forecast, by zone
4.3.5. Intraocular lens

4.3.5.1. Market size and forecast, by zone

4.3.6. Ophthalmic viscoelastic device

4.3.6.1. Market size and forecast, by zone

4.3.7. Phacoemulsification system

4.3.7.1. Market size and forecast, by zone

CHAPTER 5: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY SURGERY TYPE

5.1. Overview
5.2. Glaucoma Surgery Type

5.2.1. Market size and forecast, by surgery type
5.2.2. Conventional glaucoma surgery

5.2.2.1. Market size and forecast, by zone

5.2.3. Minimally invasive glaucoma surgery

5.2.3.1. Market size and forecast, by zone

5.3. Cataract Surgery Type

5.3.1. Market size and forecast, by surgery type
5.3.2. Phacoemulsification

5.3.2.1. Market size and forecast, by zone

5.3.3. Extracapsular cataract extraction (ECCE) surgery

5.3.3.1. Market size and forecast, by zone

5.3.4. Femtosecond laser surgery

5.3.4.1. Market size and forecast, by zone

5.3.5. Others

5.3.5.1. Market size and forecast, by zone

CHAPTER 6: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY END USERS

6.1. Overview

6.1.1. Market size and forecast, by end user

6.2. Hospital

6.2.1. Market size and forecast, by zone

6.3. Ophthalmology Clinic

6.3.1. Market size and forecast, by zone

6.4. Outpatient Surgery Centers

6.4.1. Market size and forecast, by zone

CHAPTER 7: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY ZONE

7.1. Overview

7.1.1. Market size and forecast, by zone

7.2. North Zone

7.2.1. Market size and forecast, by product
7.2.2. Market size and forecast, by surgery type
7.2.3. Market size and forecast, by end users

7.3. East Zone

7.3.1. Market size and forecast, by product
7.3.2. Market size and forecast, by surgery type
7.3.3. Market size and forecast, by end users

7.4. West Zone

7.4.1. Market size and forecast, by product
7.4.2. Market size and forecast, by surgery type
7.4.3. Market size and forecast, by end users

7.5. South Zone

7.5.1. Market size and forecast, by product
7.5.2. Market size and forecast, by surgery type
7.5.3. Market size and forecast, by end users

7.6. Central Zone

7.6.1. Market size and forecast, by product
7.6.2. Market size and forecast, by surgery type
7.6.3. Market size and forecast, by end users

7.7. North-East Zone

7.7.1. Market size and forecast, by product
7.7.2. Market size and forecast, by surgery type
7.7.3. Market size and forecast, by end users

CHAPTER 8: COMPANY PROFILES

8.1. Allergan Plc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. Carl Zeiss Meditec AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. Ellex Medical Lasers Ltd.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. Essilor International S.A.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. HOYA Corporation

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. Johnson & Johnson

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. Lumenis Ltd.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. Metall Zug AG (HAAG-Streit Holding AG)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. New World Medical, Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio

8.10. Nidek Co., Ltd.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

8.11. Novartis International AG (Alcon Inc.)

8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments

8.12. Topcon Corporation.

8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.12.6. Key strategic moves and developments

8.13. Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)

8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance
8.13.6. Key strategic moves and developments

8.14. Ziemer Ophthalmic Systems AG

8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Product portfolio